The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Are you joking.. they would not abandon a test due to a data breach in the middle of a pandemic.. especially as it’s more likely to be an innocent member of the public.. they would just issue an update RNS.
A few have mentioned investing in other pharma companies. This Co (LID) is a little gem, it sells monitoring equipment with recurring revenues in UK, US, China and RoW. cashed up, growth, global presence, USP. A very impressive BoD and only £20m MCAP! By the way I was alerted to sng with a sensible OT rec. the ppt is 14 slides 3 are headers. Enjoy,
http://www.lidco.com/wp-content/uploads/2020/02/Growth-Innovation-London-Feb-20-v2.pdf
Trek
TedB good luck with your all the holdings, i do remember some of your positive posts before,but thought that you sold now and deramping like many others do it.some people even get new IDs and start deramping as they are easy to spot.
Apology again and good luck.
Maqsood, with 5% of my pension in this one I am a long term holder and definitely not looking to deramp. Also taking a flyer on Faron and Angle. And by flyer I mean I have no idea whether they will go up or down. Just a hopeful gamble. Not ramping either of them.
Wow tedB,sorry for my silly comment,you can be really helpful for us all who doesn’t understand the process here.
Sorry I thought you are one of those guys who want to deramp to get in cheap.
Really sorry mate,and please we need your valuable expertise here.
Thanks Warwick. Worked on developing reliable HIV blood analysis in the 1980s so sometimes get a bit frustrated with the easy expertise you get on these boards. Got grandad's tinnie ready just in case.
The trials we are doing on 100 people.
Definitely a big staff is working to serve them,looking after they and monitor them 24hours,it is not cup of tea for couple of people.also many experts are involved with this process.
In that case if some news get leak is possible.
And in tough time like this,they can not afford to abandon the trials because of data breach.
We all need to understand that and also need to understand that we all need this treatment to succeed for ourselves and our families.
Hope everyone agrees with it.
SNG001 has already been effective on a list of viruses before COVID19 came about so they already have a ton of data to compare with on how the body responds for a new virus they are not going in blind. All health and safety tests passed.
Out of 20 possibilities worldwide SNG001 is one of the four treatments with high hopes for COVID19. Many have come forward, a 100 or so, saying what about this drug etc but have not passed the vetting procedure. They got is down to 20 but only 4 were feasible that they have gone for.
Bill Gates interview on TED
https://www.ted.com/talks/bill_gates_how_we_must_respond_to_the_coronavirus_pandemic/up-next#t-3095781
Hope you got your tin hat ready Ted for talking some sense!!
Watch the rampers crawl out of the woodwork and hurl abuse at you!!
BTW love your expression "keyboard experts"!!!
You are a busy poster Pilgrim - whatever board I look into you've already been there! The main problem I'm having over this weekend is working out how to allocate my investments between SNG and NCYT percentage wise - which will rise the highest and when?
Also there is FARN to consider, who seem to be currently well behind SNG's curve, but have just advertised for a clinical supply chain manager - any mileage in that one do you think?
ATB
(1)There has been s lot of chatter by keyboard experts about leaked results in order to ramp the share price. Even including a "quote" from a named American physician that Synairgen was so effective that patients were able to go home. This before the trial had even started. (2) The regulatory authorities take clinical trials more seriously than computer gamers. If the results are leaked, the trial is considered unreliable and abandoned. Surely you must remember that from your PhD training.
Ted was talking about play station game,lol.
Break the rule and go back to lower level,lol.
pilgrim1 if someone thinking about this going down to 35p then they are mistaken.
Millions of shares subscribed in 3hours and 45minutes (trading time) only!!
This will be marching up soon,not going down.
The first 2 weeks are pilot phase. If the results are leaked then presumably the whole trial is invalidated and must be abandoned. Bit of a pain.
Clinical Characterisation Protocol for Severe Emerging Infection (ISARIC)
This study is designed for the rapid, coordinated clinical investigation of patients with confirmed novel coronavirus infection. The study has been designed to maximize the likelihood that as much data as possible is collected and shared rapidly in a format that can be easily aggregated, tabulated and analysed across many different settings globally. The study is designed to have some level of flexibility in order to ensure the broadest acceptance.
SG016
A randomised double-blind placebo-controlled trial to determine the safety and efficacy of inhaled SNG001 (IFN-ß1a for nebulisation) for the treatment of patients with confirmed SARS-CoV-2 infection.
Yeah there’s a few that think it’s 6 or 8 weeks but they’ve always said 2 and you start seeing results after 48 hours. End of week 1 they’ll start to see trends compared to previous asthma/ copd tests.. I think they already know it’s positive enough hence the book build.. only a week max to wait but I’m expecting big move on Monday. Loads of pi’s thinking it may go down to 35p which when it doesn’t they’ll start jumping in en mass
Trial is led by tom wilkinson,professor at Southampton university hospital.
And AZN got contract renewed with Southampton university hospital too.
All blocks are coming together imo.
Next week will be massive for all of us.
Good luck and hold tight.
According to this,this trial will last for two weeks only.
Also there is one more update on 26th,could be just reminder??
https://www.uhs.nhs.uk/ClinicalResearchinSouthampton/Research/News-and-updates/News-and-updates.aspx